
ALVAC-CEA vaccine. Targets carcinoembryonic antigen (CEA) in colorectal cancer. It uses a modified canarypox virus (ALVAC) as a carrier to deliver the CEA protein to immune cells, stimulating an immune response against CEA-expressing cancer cells.
px | px | dpi | = | cm | x | cm | = | MB |
Details
Creative#:
TPG36143879
Source:
達志影像
Authorization Type:
RF
Release Information:
須由TPG 完整授權
Model Release:
N/A
Property Release:
N/A
Right to Privacy:
No
Same folder images:
alvacceavaccinetargetscarcinoembryonicantigenceacolorectalcanceroncologyoncologicalrecombinantusingalvacvirusviraldeliveraiminginduceimmuneresponseceaexpressingcellslaboratorymedicineresearchoncologyvaccinationinoculationimmunizationimmunisationhealthcareillnessinnovationinjectingbiotechnologynobodyno-one
aimingalvacalvacceaantigenbiotechnologycancercarcinoembryonicceaceacellscolorectaldeliverexpressinghealthcareillnessimmuneimmunisationimmunizationinduceinjectinginnovationinoculationlaboratorymedicineno-onenobodyoncologicaloncologyoncologyrecombinantresearchresponsetargetsusingvaccinationvaccineviralvirus